Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander J Robins

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Opinion in Lipidology|November 19, 2003
Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?Sander J Robins
Current Cardiology Reports|November 1, 2005
Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndromeSander J Robins
Lancet (London, England)|December 14, 2002
MRC/BHF Heart Protection StudySander J Robins, Jean-Pierre Despres,
Current Opinion in Lipidology|July 13, 2006
Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trialsSander J Robins, Hanna E Bloomfield
Drugs|October 1, 2004
Role of fibric acid derivatives in the management of risk factors for coronary heart diseaseJean-Pierre Després, Isabelle Lemieux, Sander J Robins
Current Atherosclerosis Reports|June 8, 2002
Treatment of lipid disorders after strokeJoao A Gomes, Sander J Robins, Viken L Babikian
Atherosclerosis|March 6, 2007
Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)Sander J Robins, Dorothea Collins, Judith R McNamara, et al.
Diabetologia|September 28, 2015
Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart StudyCharlotte Andersson, Asya Lyass, Martin G Larson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 22, 2008
Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention TrialSander J Robins, Dorothea Collins, Jeanenne J Nelson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 2011
Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the Framingham Heart StudySander J Robins, Asya Lyass, Justin P Zachariah, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Opinion in Lipidology|November 19, 2003
Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?Sander J Robins
Current Cardiology Reports|November 1, 2005
Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndromeSander J Robins
Lancet (London, England)|December 14, 2002
MRC/BHF Heart Protection StudySander J Robins, Jean-Pierre Despres,
Current Opinion in Lipidology|July 13, 2006
Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trialsSander J Robins, Hanna E Bloomfield
Drugs|October 1, 2004
Role of fibric acid derivatives in the management of risk factors for coronary heart diseaseJean-Pierre Després, Isabelle Lemieux, Sander J Robins
Current Atherosclerosis Reports|June 8, 2002
Treatment of lipid disorders after strokeJoao A Gomes, Sander J Robins, Viken L Babikian
Atherosclerosis|March 6, 2007
Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)Sander J Robins, Dorothea Collins, Judith R McNamara, et al.
Diabetologia|September 28, 2015
Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart StudyCharlotte Andersson, Asya Lyass, Martin G Larson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 22, 2008
Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention TrialSander J Robins, Dorothea Collins, Jeanenne J Nelson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 2011
Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the Framingham Heart StudySander J Robins, Asya Lyass, Justin P Zachariah, et al.
Pageof 5